Owning discovered the palmitoylation motif of APLNR, we created a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the development of NCP, together with pain incidence, microglial activation, and inflammatory component https://juliusdsydf.canariblogs.com/the-best-side-of-block-pain-receptors-with-proleviate-41821116